Allucent

Allucent is a privately held, revenue-generating CRO founded in 2003, serving as a strategic partner for biotech and small-to-mid-size pharmaceutical companies. It leverages deep therapeutic expertise in complex areas like oncology and neuroscience, combined with a global operational footprint, to guide clients through all phases of clinical development and regulatory submission. The company differentiates itself through a nimble, collaborative 'A-Team' approach, positioning it as a specialized alternative to larger, more bureaucratic CROs in a growing market driven by biopharma innovation.

Integrated clinical development service platform combining deep therapeutic expertise, clinical pharmacology (PK/PD modeling, simulation), regulatory strategy, and global operational execution for biopharma clients.

Allucent competes in the crowded global CRO market, differentiating itself by focusing on small-to-mid-size biopharma with a flexible, partnership-driven model. Key competitors include large public CROs (e.g., IQVIA, ICON) with broader resources and smaller niche CROs with specific therapeutic or geographic focus.